Eli Lilly Stock Hits a New All-Time High: Has It Gotten Too Expensive to Buy?

Eli Lilly Revenue Surges 55.5% on Mounjaro Sales, But Stock Lags Amid Pricing Pressures

Eli Lilly reported strong Q1 results with 55.5% revenue growth to $19.80 billion, driven by Mounjaro's $8.66 billion in sales. The company r

This $1,200 Stock Could Be the Next Massive Stock Split Opportunity

Eli Lilly to acquire three vaccine manufacturers for up to $3.8 billion

Eli Lilly is spending up to $3.8 billion to acquire three vaccine manufacturing companies, significantly expanding its presence in the immun

Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity

Can Apple Stock Reach $400 This Year? 3 Catalysts That Can Make It Happen

Apple’s stock recovers after hit from unprecedented price hikes on products